Labopharm Gets FDA Approval For Once-Daily Trazodone Drug

Date : 02/03/2010 @ 8:24AM
Source : Dow Jones News
Stock : Labopharm Inc. (MM) (DDSS)
Quote : 0.14  0.0 (0.00%) @ 2:05AM

Labopharm Gets FDA Approval For Once-Daily Trazodone Drug

Labopharm Inc. (MM) (NASDAQ:DDSS)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Labopharm Inc. (MM) Charts.

Labopharm Inc. (DDSS) has received U.S. Food and Drug Administration approval for its once-daily formulation of the antidepressant trazodone for adults.

The FDA had been expected to make an approval decision by Feb. 11.

Labopharm's OLEPTRO Extended Release Tablets have been approved for the treatment of major depressive disorder in adults.

The Canadian specialty-pharma company said it's actively exploring several alternatives for the U.S. commercialization of OLEPTRO and expects the drug to be available for prescription in the U.S. later this year.

Labopharm said it will conduct a post-approval pediatric study. The FDA has asked it to provide data from a long-term maintenance study and an additional in-vitro alcohol dissolution study.

On Nasdaq Tuesday, Labopharm closed at $2.61, down 1.9%. In pre-market trading Wednesday, it's up about 15%.

-By Judy McKinnon, Dow Jones Newswires; 416-306-2100; judy.mckinnon@dowjones.com

 
 



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.